Literature DB >> 22496387

A risk model for lung cancer incidence.

Clive Hoggart1, Paul Brennan, Anne Tjonneland, Ulla Vogel, Kim Overvad, Jane Nautrup Østergaard, Rudolf Kaaks, Federico Canzian, Heiner Boeing, Annika Steffen, Antonia Trichopoulou, Christina Bamia, Dimitrios Trichopoulos, Mattias Johansson, Domenico Palli, Vittorio Krogh, Rosario Tumino, Carlotta Sacerdote, Salvatore Panico, Hendriek Boshuizen, H Bas Bueno-de-Mesquita, Petra H M Peeters, Eiliv Lund, Inger Torhild Gram, Tonje Braaten, Laudina Rodríguez, Antonio Agudo, Emilio Sánchez-Cantalejo, Larraitz Arriola, Maria-Dolores Chirlaque, Aurelio Barricarte, Torgny Rasmuson, Kay-Tee Khaw, Nicholas Wareham, Naomi E Allen, Elio Riboli, Paolo Vineis.   

Abstract

Risk models for lung cancer incidence would be useful for prioritizing individuals for screening and participation in clinical trials of chemoprevention. We present a risk model for lung cancer built using prospective cohort data from a general population which predicts individual incidence in a given time period. We build separate risk models for current and former smokers using 169,035 ever smokers from the multicenter European Prospective Investigation into Cancer and Nutrition (EPIC) and considered a model for never smokers. The data set was split into independent training and test sets. Lung cancer incidence was modeled using survival analysis, stratifying by age started smoking, and for former smokers, also smoking duration. Other risk factors considered were smoking intensity, 10 occupational/environmental exposures previously implicated with lung cancer, and single-nucleotide polymorphisms at two loci identified by genome-wide association studies of lung cancer. Individual risk in the test set was measured by the predicted probability of lung cancer incidence in the year preceding last follow-up time, predictive accuracy was measured by the area under the receiver operator characteristic curve (AUC). Using smoking information alone gave good predictive accuracy: the AUC and 95% confidence interval in ever smokers was 0.843 (0.810-0.875), the Bach model applied to the same data gave an AUC of 0.775 (0.737-0.813). Other risk factors had negligible effect on the AUC, including never smokers for whom prediction was poor. Our model is generalizable and straightforward to implement. Its accuracy can be attributed to its modeling of lifetime exposure to smoking. ©2012 AACR.

Entities:  

Mesh:

Year:  2012        PMID: 22496387      PMCID: PMC4295118          DOI: 10.1158/1940-6207.CAPR-11-0237

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  34 in total

Review 1.  The health benefits of smoking cessation.

Authors:  J M Samet
Journal:  Med Clin North Am       Date:  1992-03       Impact factor: 5.456

2.  A risk model for prediction of lung cancer.

Authors:  Margaret R Spitz; Waun Ki Hong; Christopher I Amos; Xifeng Wu; Matthew B Schabath; Qiong Dong; Sanjay Shete; Carol J Etzel
Journal:  J Natl Cancer Inst       Date:  2007-05-02       Impact factor: 13.506

3.  Personal genomes: The case of the missing heritability.

Authors:  Brendan Maher
Journal:  Nature       Date:  2008-11-06       Impact factor: 49.962

4.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Authors:  Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston
Journal:  Nat Genet       Date:  2008-04-02       Impact factor: 38.330

5.  Modifying risk of developing lung cancer by changing habits of cigarette smoking.

Authors:  J H Lubin; W J Blot; F Berrino; R Flamant; C R Gillis; M Kunze; D Schmähl; G Visco
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-30

6.  Patterns of absolute risk of lung cancer mortality in former smokers.

Authors:  M T Halpern; B W Gillespie; K E Warner
Journal:  J Natl Cancer Inst       Date:  1993-03-17       Impact factor: 13.506

7.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.

Authors:  E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

8.  Differences in lung cancer risk between men and women: examination of the evidence.

Authors:  E A Zang; E L Wynder
Journal:  J Natl Cancer Inst       Date:  1996-02-21       Impact factor: 13.506

9.  Common 5p15.33 and 6p21.33 variants influence lung cancer risk.

Authors:  Yufei Wang; Peter Broderick; Emily Webb; Xifeng Wu; Jayaram Vijayakrishnan; Athena Matakidou; Mobshra Qureshi; Qiong Dong; Xiangjun Gu; Wei Vivien Chen; Margaret R Spitz; Timothy Eisen; Christopher I Amos; Richard S Houlston
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

10.  The LLP risk model: an individual risk prediction model for lung cancer.

Authors:  A Cassidy; J P Myles; M van Tongeren; R D Page; T Liloglou; S W Duffy; J K Field
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

View more
  30 in total

Review 1.  Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals.

Authors:  Jiu-Wei Cui; Wei Li; Fu-Jun Han; Yu-Di Liu
Journal:  Transl Lung Cancer Res       Date:  2015-06

Review 2.  Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.

Authors:  Emma Louise O'Dowd; David R Baldwin
Journal:  Br J Radiol       Date:  2017-10-17       Impact factor: 3.039

3.  Region specific lung nodule management practice guideline.

Authors:  Scott Apperley; Stephen Lam
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

4.  Selecting high-risk individuals for lung cancer screening; the use of risk prediction models vs. simplified eligibility criteria.

Authors:  Rudolf Kaaks; Anika Hüsing; Renée T Fortner
Journal:  Ann Transl Med       Date:  2017-10

5.  Cancer Progress and Priorities: Lung Cancer.

Authors:  Matthew B Schabath; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

6.  Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.

Authors:  Hormuzd A Katki; Stephanie A Kovalchik; Lucia C Petito; Li C Cheung; Eric Jacobs; Ahmedin Jemal; Christine D Berg; Anil K Chaturvedi
Journal:  Ann Intern Med       Date:  2018-05-15       Impact factor: 25.391

7.  Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Authors:  Hormuzd A Katki; Stephanie A Kovalchik; Christine D Berg; Li C Cheung; Anil K Chaturvedi
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

8.  Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement.

Authors:  Peter Mazzone; Charles A Powell; Douglas Arenberg; Peter Bach; Frank Detterbeck; Michael K Gould; Michael T Jaklitsch; James Jett; David Naidich; Anil Vachani; Renda Soylemez Wiener; Gerard Silvestri
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

Review 9.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

10.  The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model.

Authors:  Randa A El-Zein; Mirtha S Lopez; Anthony M D'Amelio; Mei Liu; Reginald F Munden; David Christiani; Li Su; Paula Tejera-Alveraz; Rihong Zhai; Margaret R Spitz; Carol J Etzel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-29       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.